ADVERTISEMENTs
.png)
Jatinder Palta appointed director of new medical physics institute
Palta is an internationally recognized expert in advanced radiotherapy techniques, quality assessment, and assurance.
 (1).jpeg)
Jatinder Palta. / Image – AAPM
Indian-American physician Jatinder Palta, has been appointed as the first director of the Medical Physics Institute (MPI) under the American Association of Physicists in Medicine (AAPM).
Approved by the AAPM board of directors in 2023, MPI aims to improve the quality and safety of patient care in radiology and radiation oncology. It will focus on early assessment and direction when new technologies are developed and plans to collaborate with imaging and radiotherapy equipment vendors. MPI will become an international resource for healthcare providers, regulatory bodies, funding agencies, and equipment manufacturers.
Palta will retire from his role as tenured professor and chairman of Medical Physics in the Department of Radiation Oncology at Virginia Commonwealth University at the end of this academic year. “I am really thrilled to take on the responsibility of heading MPI as its inaugural director,” he said.
“I am looking forward to working with AAPM subject matter experts, vendor partners, and government agencies to make MPI successful in its vision and mission of providing resources for safe medical physics practice and opportunities for AAPM to grow its portfolio,” Palta added.
“MPI will serve a critical need in industry as new physics-related technologies and tools are applied in medicine, all in pursuit of improving human health,” said AAPM’s executive director C. David Gammel. “I am excited to partner with Dr. Palta to launch the Institute as an important new addition to AAPM.”
Palta, an AAPM Fellow since 1996 and recipient of the William D. Coolidge Gold Medal Award in 2017, brings extensive experience and leadership to MPI. As director, he will oversee MPI’s consulting services, technology assessment, guidance on standardization processes, and development of quality assurance for new treatment techniques. MPI’s stakeholders include professional societies, government agencies, educational institutions, equipment vendors, and patients.
An internationally recognized expert in advanced radiotherapy techniques, quality assessment, and assurance, he has significantly contributed to radiation oncology and medical physics through research, inventions, and over 200 publications.
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login